1 / 5
Pipmed Medical
Pipmed Medical
Indocyanine green (ICG) is a near-infrared fluorescent dye. Protein-bound ICG can be excited by external light with a wavelength range of 750 ~ 810 nm, and emits near-infrared light with a wavelength of about 840nm. Its half-life in blood is about 3 ~ 5 minutes. After entering the blood and binding to protein, it is absorbed by liver cells, then enters the intestine through the biliary tract, and finally is excreted with feces.
This indocyanine green injection has passed double consistency evaluations. With its high purity, low impurity content, and optimized storage conditions, ICG brings stable and reliable diagnosis and treatment options to the medical community.
Indications: Detection of choroidal neovascularization, macular lesions, intraocular tumors, and retinal vascular lesions; Intraoperative staining of capsule and internal limiting membrane.
Advantages: Provides clear choroidal vascular images for accurate diagnosis. In cataract and retinal surgery, fluorescent staining helps identify and treat membranes accurately, reducing complications.
Indications: Evaluation of liver reserve function, liver tumor imaging, liver segment identification, and biliary tract development observation.
Advantages: Rapid, accurate, and safe method to evaluate liver function. Helps physicians identify liver structures clearly, improving surgical safety.
Indications: Accurate localization of tumors, imaging of the lymphatic system, and assessment of blood supply.
Advantages: The fluorescence signal makes it intuitive to judge targets, enhancing visibility during operations.
The product range includes research, development, and production of high-end medical devices (fluorescence imaging series), fluorescence contrast agents (ICG, targeted series), and core components (CMOS camera modules, endoscopes), providing full-chain solutions used in over 500 large hospitals.
Founded in 2011, the enterprise focuses on core technologies such as molecular fluorescence, Raman spectroscopy, AI, and computer-aided drug molecular design (CADD). The mission is to become a global leader in molecular fluorescence technology through the synergy of medical devices and pharmaceuticals.
As a specialized "little giant" enterprise, we hold 131 core invention patents and 7 US invention patents. We have undertaken numerous national and provincial R&D projects in the field of molecular fluorescence.
The company is a strategic partner of international leading companies and has established cooperative businesses with more than 10 overseas countries.
